Family Medicine Initiative
APRIL 9, 2024
4 Chronic Kidney Disease The FLOW trial randomized 3,534 patients with chronic kidney disease and type 2 diabetes and started treating them with s.c. Both the FDA and EMA recommend that doctors monitor patients with diabetic retinopathy who are undergoing semaglutide treatment closely. semaglutide 1.0 mg or placebo in 2019.
Annals of Family Medicine
NOVEMBER 20, 2024
Dataset: NHANES 1999-2004 linked to the National Death Index which provides population estimates of the US population. After a sensitivity analysis in men aged 20-49, healthy BF% was defined as < 28 and unhealthy BF% as >=28. 15-year mortality risk for the predictors of BMI and BF% was computed. 19.62, P= 0.02).
Pamela Wible MD
JUNE 19, 2025
I’m really into fasting but fasting is contraindicated if you’re diabetic and a number of other conditions I saw on the slide (in an earlier talk). I was suicidal myself as a physician and I survived that in 2004. Sexual harassment is a human rights violation. And then one of my favorite—food and water restriction.
Expert insights. Personalized for you.
130 
Let's personalize your content